Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Metsera, Inc.

MTSRNASDAQ
Healthcare
Biotechnology
$70.50
$-0.25(-0.35%)
U.S. Market is Open • 12:27

Metsera, Inc. (MTSR) Stock Overview

Explore Metsera, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap7.4B
P/E Ratio-23.55
EPS (TTM)$-2.99
ROE-0.80%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$148.30

MTSR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Metsera, Inc. (MTSR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 0.00, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $148.30.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -23.55 and a market capitalization of 7.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
97.65%
6-Month Change
139.96%
Year-to-Date (YTD) Change
166.04%
1-Year Change
166.04%
3-Year Change
166.04%
5-Year Change
166.04%
All-Time (Max) Change
166.04%

Contact Information

212 784 6595
3 World Trade Center, New York City, NY, 10007

Company Facts

930 Employees
IPO DateJan 31, 2025
CountryUS

Frequently Asked Questions